Exousia Bio, Inc. (LMMY) stock
LMMYOTCServices-Educational ServicesFiscal year ends May 31
$0.01−0.00 (-18.29%)
Close on Oct 19, 2026Market cap $175.47KP/E –Yield –
Exousia Bio operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Exousia Bio's operating income for the twelve months ending Feb 29, 2024 was -$55.08K. For fiscal 2023 it was -$56.42K.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | May 31, 2023 | -$56.42K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | $0 | -100.0% |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -$237.01K | – |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -$31.81K | – |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | $0 | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $6.98K | – |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -$4.34K | – |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$8.70K | – |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -$7.45K | – |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | -$12.16K | – |
| Q4 FY2023CQ2 2023 | May 31, 2023 | -$26.78K | – |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | -$8.27K | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -$8.41K | – |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | -$12.97K | – |
See a number that looks wrong?